AI assistant
Sending…
FEDEX CORP — Director's Dealing 2024
Sep 24, 2024
29990_dirs_2024-09-24_51e56805-74fa-4c40-90c5-1d440c4768e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FEDEX CORP (FDX)
CIK: 0001048911
Period of Report: 2024-09-24
Reporting Person: ADAMS GINA F. (EVP GENL COUNSEL/SECTY)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18228 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $180.82 | 2025-06-08 | Common Stock (4770) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $162.82 | 2026-06-06 | Common Stock (5655) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $207.305 | 2027-06-12 | Common Stock (5035) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $261.78 | 2028-06-11 | Common Stock (3820) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $161.85 | 2029-06-10 | Common Stock (7085) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $130.96 | 2030-06-15 | Common Stock (7710) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $294.605 | 2031-06-14 | Common Stock (2830) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $226.945 | 2032-06-30 | Common Stock (3685) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $229.595 | 2033-06-22 | Common Stock (3155) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $292.13 | 2034-06-27 | Common Stock (2210) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $258.115 | 2034-09-23 | Common Stock (10791) | Direct |
Footnotes
F1: These options vest ratably over four years from the date of grant and are first exercisable one year from date of grant.
More from FEDEX CORP
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 22
Board/Management Information
2026
May 18
Board/Management Information
2026
Apr 13
Director's Dealing
2026
Mar 23
Interim / Quarterly Report
2026
Mar 19
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 20
M&A Activity
2026
Feb 9
Capital/Financing Update
2026
Feb 5